Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-124163
Filing Date
2020-04-29
Accepted
2020-04-29 06:09:50
Documents
4
Period of Report
2020-06-17
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d852603ddef14a.htm DEF 14A 425545
2 GRAPHIC g852603g57x68.jpg GRAPHIC 335149
3 GRAPHIC g852603g73x73.jpg GRAPHIC 250861
4 GRAPHIC g852603g86t40.jpg GRAPHIC 19686
  Complete submission text file 0001193125-20-124163.txt   1261290
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

EIN.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35670 | Film No.: 20827162
SIC: 2834 Pharmaceutical Preparations